Literature DB >> 8585266

Role of basic fibroblast growth factor and platelet-derived growth factor (B-chain) in neointima formation after arterial injury.

V Lindner1.   

Abstract

Balloon catheterization of rat arteries induces proliferation of smooth muscle cells (SMC) which leads to the formation of an intimal lesion. We have previously demonstrated that basic fibroblast growth factor (FGF-2) released from damaged SMC is responsible for initiating SMC proliferation, however, it is still unclear which factors are involved in the continued replication of intimal SMC. Over 95% of SMC accumulating in the intima within 8 days after balloon injury are replicating and were therefore studied as an example of a proliferating SMC, while intimal SMCs at 6 weeks after injury served as a model of quiescent SMC. When in situ hybridization for FGF-2 was carried out on en face preparations at various time points after balloon injury, increased expression of FGF-2 mRNA and protein were observed at early stages when SMC were replicating while no expression was detectable in quiescent SMCs. Strong immunoreactivity for FGF-2 was found in the cytoplasm and nucleus of proliferating SMC, whereas staining in quiescent SMC was predominantly nuclear. Platelet-derived growth factor B-chain (PDGF-B) was expressed by a subpopulation of luminal SMC during formation of the neointima. The time-course of expression for FGF-receptor 1 (FGFR-1) was similar to FGF-2 with an increase in proliferating SMC. Our data suggest that the FGF-2/FGFR-1 system may play a role in the continued proliferation of intimal SMCs, while PDGF-B may be promoting intimal lesion formation by stimulating SMC migration via its chemotactic effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585266

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  5 in total

1.  Gene profiling of the rat medial collateral ligament during early healing using microarray analysis.

Authors:  Connie S Chamberlain; Sabrina H Brounts; David G Sterken; Kevin I Rolnick; Geoffrey S Baer; Ray Vanderby
Journal:  J Appl Physiol (1985)       Date:  2011-05-19

2.  Production of a recombinant human basic fibroblast growth factor with a collagen binding domain.

Authors:  J A Andrades; J A Santamaría; L T Wu; F L Hall; M E Nimni; J Becerra
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

3.  Epac1 deficiency inhibits basic fibroblast growth factor-mediated vascular smooth muscle cell migration.

Authors:  Yuko Kato; Utako Yokoyama; Takayuki Fujita; Masanari Umemura; Tetsuo Kubota; Yoshihiro Ishikawa
Journal:  J Physiol Sci       Date:  2018-08-06       Impact factor: 2.781

4.  Intracellular localization of Cthrc1 characterizes differentiated smooth muscle.

Authors:  Renée J Leclair; Qiaozeng Wang; Meredith A Benson; Igor Prudovsky; Volkhard Lindner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-08       Impact factor: 8.311

5.  FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression.

Authors:  Pei-Yu Chen; Michael Simons; Robert Friesel
Journal:  J Biol Chem       Date:  2009-04-01       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.